Clinical outcome of chemoradiotherapy for T1G3 bladder cancer

International Journal of Urology

Volumn 15, Issue 8, 2008, Pages 747-750

  Inoue, Masaharu ^a   Ishioka, Jun Ichiro ^a   Fukuda, Hiroshi ^a   Kageyama, Yukio ^a   Saito, Yoshihiro ^a   Higashi, Yotsuo ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Bladder cancer; Chemoradiotherapy; T1G3

Indexed keywords

BCG VACCINE; CISPLATIN; METHOTREXATE;

ADULT; AGED; ANEMIA; ARTICLE; BLADDER CANCER; BLADDER FUNCTION; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; CYSTITIS; DIARRHEA; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; MINIMAL RESIDUAL DISEASE; NAUSEA AND VOMITING; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; THROMBOCYTOPENIA; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 49549109858     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02077.x     Document Type: Article

References (31)

1. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J. Urol. 2002 167 : 1573 83.
2. Smith JA Jr., Labasky RF, Cockett AT et al. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS): The American Urological Association. J. Urol. 1999 162 : 1697 701.
3. Amling CL, Thrasher JB, Frazier HA et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J. Urol. 1994 151 : 31 6.
4. Freeman JA, Esrig D, Stein JP et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995 76 : 833 9.
5. Malkowicz SB, Nichols P, Lieskovsky G et al. The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J. Urol. 1990 144 : 641 5.
6. May M, Helke C, Nitzke T et al. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol. Int. 2004 72 : 103 11.
7. Shipley WU, Kaufman DS, Tester WJ et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 2003 97 : 2115 9.
8. Rödel C, Weiss C, Sauer R. Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin. Radiat. Oncol. 2005 95 : 786 90.
9. Kageyama Y, Yokoyama M, Sakai Y et al. Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer. Am. J. Clin. Oncol. 2003 26 : 504 7.
10. AJCC Cancer Staging Manual. 6th ed. Springer, New York, NY, 2002 335 40.
11. Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin. Radiat. Oncol. 2003 13 : 176 81.
12. Weiss C, Wolze C, Engehausen DG et al. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? J. Clin. Oncol. 2006 24 : 2318 24.
13. Cookson MS, Sarosdy MF. Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin. J. Urol. 1992 148 : 797 801.
14. Serretta V, Piazza S, Pavone C et al. Result of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder. Urology 1996 47 : 647 51.
15. Zhang GK, Ute ET, Sharer WC et al. Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. J. Urol. 1996 155 : 1907 9.
16. Baniel J, Grauss D, Engelstein D et al. Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder. Urology 1998 52 : 785 9.
17. Hurle R, Losa A, Manzetti A et al. Intravesical bacillus Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7 year follow-up. Urology 1999 54 : 258 63.
18. Gohji K, Nomi M, Okamoto M et al. Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 1999 53 : 308 13.
19. Brake M, Loertzer H, Horsch R et al. Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer. Urology 2000 55 : 673 8.
20. Patard J, Moudouni S, Saint F et al. Tumor progression and survival in patients with T1G3 bladder tumors: Multicentric retrospective study comparing 94 patients treated during 17 years. Urology 2001 58 : 551 6.
21. Iori F, di Seri M, de Nunzio C et al. Long term maintenance bacillus Calmette-Guerin therapy in high-grade superficial bladder cancer. Urology 2002 59 : 414 18.
22. Kulkarni JN, Gupta R. Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guerin (Danish 1331 strain). BJU Int. 2002 90 : 554 7.
23. Pansadoro V, Emiliozzi P, de Paula F et al. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacilli Calmette-Guerin: 18-year experience. Urology 2002 59 : 227 31.
24. Paymaure M, Zerbib M. T1G3 transitional cell carcinoma of the bladder: Recurrence, progression and survival. BJU Int. 2004 93 : 60 3.
25. Shahin O, Thalmann GN, Rentsch C et al. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival. J. Urol. 2003 169 : 96 100.
26. Thalmann GN, Markwalder R, Shanin O et al. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J. Urol. 2004 172 : 70 5.
27. Gunlusoy B, Degirmenci T, Arslan M et al. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin. Urol. Int. 2005 75 : 107 13.
28. Denzinger S, Otto W, Fritsche HM et al. Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients. Int. J. Urol. 2007 14 : 995 9.
29. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J. Clin. Oncol. 2001 19 : 666 75.
30. Masood S, Sriprasad S, Palmer JH et al. T1G3 bladder cancer: indications for early cystectomy. Int. Urol. Nephrol. 2004 36 : 41 4.
31. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J. Urol. 2006 176 : 2414 22.